Oramed Pharmaceuticals is a pharmaceutical company. Co. is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. Co.'s primary product, ORMD-0801, is an orally ingestible insulin capsule for the treatment of diabetes. In addition to its key product, the ORMD-0801 insulin capsule, Co. is using its technology for an orally ingestible Glucagon-like peptide-1 capsule, or ORMD-0901. Co. is developing a drug candidate, a weight loss treatment in the form of an oral leptin capsule.
|
Free ORMP Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Hold (2.00 out of 4) 0th percentile
(ranked lower than approx. 100% of all stocks covered)
Analysts' Target Price: ORMP Stock Forecast Based on Zacks ABR data; powered by Xignite |